Combination anti-CD 74 ( milatuzumab ) and anti-CD 20 ( rituximab ) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
暂无分享,去创建一个
J. Byrd | G. Lozanski | M. Prætorius-Ibba | R. Baiocchi | K. Blum | B. Christian | O. O’Connor | L. Alinari | Bo Yu | N. Muthusamy | D. Goldenberg | Xiaoli Zhang | R. Lapalombella | Fengting Yan | Jungook D. Shin | M. Lustberg | C. Quinion | E. Hertlein | Xiaoli Zhang | Carl D Quinion